{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31223427", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "05", "Day": "16"}], "Language": ["eng"], "ELocationID": ["8512048", "10.1155/2019/8512048"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2019", "PubDate": {"Year": "2019"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Antioxidant and Anti-inflammatory Mechanisms of Neuroprotection by Ursolic Acid: Addressing Brain Injury, Cerebral Ischemia, Cognition Deficit, Anxiety, and Depression.", "Pagination": {"StartPage": "8512048", "MedlinePgn": "8512048"}, "Abstract": {"AbstractText": ["Ursolic acid (UA) is a pentacyclic triterpene which is found in common herbs and medicinal plants that are reputed for a variety of pharmacological effects. Both as an active principle of these plants and as a nutraceutical ingredient, the pharmacology of UA in the CNS and other organs and systems has been extensively reported in recent years. In this communication, the antioxidant and anti-inflammatory axis of UA's pharmacology is appraised for its therapeutic potential in some common CNS disorders. Classic examples include the traumatic brain injury (TBI), cerebral ischemia, cognition deficit, anxiety, and depression. The pharmacological efficacy for UA is demonstrated through the therapeutic principle of one drug \u2192 multitargets \u2192 one/many disease(s). Both specific enzymes and receptor targets along with diverse pharmacological effects associated with oxidative stress and inflammatory signalling are scrutinised."]}, "AuthorList": [{"Identifier": ["0000-0001-6743-2244"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Research Laboratories & Herbal Analysis Services, University of Greenwich, Central Avenue, Chatham-Maritime, Kent ME4 4TB, UK."}], "LastName": "Habtemariam", "ForeName": "Solomon", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Anxiety"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Brain Ischemia"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Cognitive Dysfunction"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Triterpenes"}, {"QualifierName": [], "DescriptorName": "Ursolic Acid"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Iqbal J., Abbasi B. A., Ahmad R., et al. Ursolic acid a promising candidate in the therapeutics of breast cancer: current status and future implications. Biomedicine & Pharmacotherapy. 2018;108:752\u2013756. doi: 10.1016/j.biopha.2018.09.096.", "ArticleIdList": ["10.1016/j.biopha.2018.09.096", "30248543"]}, {"Citation": "Yin R., Li T., Tian J. X., Xi P., Liu R. H. Ursolic acid, a potential anticancer compound for breast cancer therapy. Critical Reviews in Food Science and Nutrition. 2018;58(4):568\u2013574. doi: 10.1080/10408398.2016.1203755.", "ArticleIdList": ["10.1080/10408398.2016.1203755", "27469428"]}, {"Citation": "Katashima C. K., Silva V. R., Gomes T. L., Pichard C., Pimentel G. D. Ursolic acid and mechanisms of actions on adipose and muscle tissue: a systematic review. Obesity Reviews. 2017;18(6):700\u2013711. doi: 10.1111/obr.12523.", "ArticleIdList": ["10.1111/obr.12523", "28335087"]}, {"Citation": "Mancha-Ramirez A. M., Slaga T. J. Ursolic acid and chronic disease: an overview of UA\u2019s effects on prevention and treatment of obesity and cancer. Advances in Experimental Medicine and Biology. 2016;928:75\u201396. doi: 10.1007/978-3-319-41334-1_4.", "ArticleIdList": ["10.1007/978-3-319-41334-1_4", "27671813"]}, {"Citation": "Seo D. Y., Lee S. R., Heo J. W., et al. Ursolic acid in health and disease. The Korean Journal of Physiology & Pharmacology. 2018;22(3):235\u2013248. doi: 10.4196/kjpp.2018.22.3.235.", "ArticleIdList": ["10.4196/kjpp.2018.22.3.235", "PMC5928337", "29719446"]}, {"Citation": "Kashyap D., Sharma A., Tuli H. S., Punia S., Sharma A. K. Ursolic acid and oleanolic acid: pentacyclic terpenoids with promising anti-inflammatory activities. Recent Patents on Inflammation & Allergy Drug Discovery. 2016;10(1):21\u201333. doi: 10.2174/1872213X10666160711143904.", "ArticleIdList": ["10.2174/1872213X10666160711143904", "27531153"]}, {"Citation": "Toglia J., Golisz K. Changes in the Brain: Impact on Daily Life. Springer; 2017. Traumatic brain injury (TBI) and the impact on daily life; pp. 117\u2013143.", "ArticleIdList": ["10.1007/978-0-387-98188-8_6"]}, {"Citation": "Donat C. K., Scott G., Gentleman S. M., Sastre M. Microglial activation in traumatic brain injury. Frontiers in Aging Neuroscience. 2017;9:p. 208. doi: 10.3389/fnagi.2017.00208.", "ArticleIdList": ["10.3389/fnagi.2017.00208", "PMC5487478", "28701948"]}, {"Citation": "Lee S. W., Gajavelli S., Spurlock M. S., et al. Microglial inflammasome activation in penetrating ballistic-like brain injury. Journal of Neurotrauma. 2018;35(14):1681\u20131693. doi: 10.1089/neu.2017.5530.", "ArticleIdList": ["10.1089/neu.2017.5530", "PMC6016174", "29439605"]}, {"Citation": "Liddelow S. A., Guttenplan K. A., Clarke L. E., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u2013487. doi: 10.1038/nature21029.", "ArticleIdList": ["10.1038/nature21029", "PMC5404890", "28099414"]}, {"Citation": "Hasan A., Deeb G., Rahal R., et al. Mesenchymal stem cells in the treatment of traumatic brain injury. Frontiers in Neurology. 2017;8(28) doi: 10.3389/fneur.2017.00028.", "ArticleIdList": ["10.3389/fneur.2017.00028", "PMC5316525", "28265255"]}, {"Citation": "James S. L., Theadom A., Ellenbogen R. G., et al. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019;18(1):56\u201387. doi: 10.1016/S1474-4422(18)30415-0.", "ArticleIdList": ["10.1016/S1474-4422(18)30415-0", "PMC6291456", "30497965"]}, {"Citation": "Boldrini M., Fulmore C. A., Tartt A. N., et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018;22(4):589\u2013599.e5. doi: 10.1016/j.stem.2018.03.015.", "ArticleIdList": ["10.1016/j.stem.2018.03.015", "PMC5957089", "29625071"]}, {"Citation": "Eriksson P. S., Perfilieva E., Bj\u00f6rk-Eriksson T., et al. Neurogenesis in the adult human hippocampus. Nature Medicine. 1998;4(11):1313\u20131317. doi: 10.1038/3305.", "ArticleIdList": ["10.1038/3305", "9809557"]}, {"Citation": "Spalding K. L., Bergmann O., Alkass K., et al. Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013;153(6):1219\u20131227. doi: 10.1016/j.cell.2013.05.002.", "ArticleIdList": ["10.1016/j.cell.2013.05.002", "PMC4394608", "23746839"]}, {"Citation": "Sorrells S. F., Paredes M. F., Cebrian-Silla A., et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018;555(7696):377\u2013381. doi: 10.1038/nature25975.", "ArticleIdList": ["10.1038/nature25975", "PMC6179355", "29513649"]}, {"Citation": "Habtemariam S. Molecular pharmacology of rosmarinic and salvianolic acids: potential seeds for Alzheimer\u2019s and vascular dementia drugs. International Journal of Molecular Sciences. 2018;19(2):p. 458. doi: 10.3390/ijms19020458.", "ArticleIdList": ["10.3390/ijms19020458", "PMC5855680", "29401682"]}, {"Citation": "Ding H., Wang H., Zhu L., Wei W. Ursolic acid ameliorates early brain injury after experimental traumatic brain injury in mice by activating the Nrf2 pathway. Neurochemical Research. 2017;42(2):337\u2013346. doi: 10.1007/s11064-016-2077-8.", "ArticleIdList": ["10.1007/s11064-016-2077-8", "27734181"]}, {"Citation": "Zhang T., Su J., Guo B., Zhu T., Wang K., Li X. Ursolic acid alleviates early brain injury after experimental subarachnoid hemorrhage by suppressing TLR4-mediated inflammatory pathway. International Immunopharmacology. 2014;23(2):585\u2013591. doi: 10.1016/j.intimp.2014.10.009.", "ArticleIdList": ["10.1016/j.intimp.2014.10.009", "25466266"]}, {"Citation": "Zhang T., Su J., Wang K., Zhu T., Li X. Ursolic acid reduces oxidative stress to alleviate early brain injury following experimental subarachnoid hemorrhage. Neuroscience Letters. 2014;579:12\u201317. doi: 10.1016/j.neulet.2014.07.005.", "ArticleIdList": ["10.1016/j.neulet.2014.07.005", "25026072"]}, {"Citation": "Sahu S., Li R., Kadeyala P. K., Liu S., Schachner M. The human natural killer-1 (HNK-1) glycan mimetic ursolic acid promotes functional recovery after spinal cord injury in mouse. The Journal of Nutritional Biochemistry. 2018;55:219\u2013228. doi: 10.1016/j.jnutbio.2018.01.016.", "ArticleIdList": ["10.1016/j.jnutbio.2018.01.016", "29567576"]}, {"Citation": "Li L., Zhang X., Cui L., et al. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice. Brain Research. 2013;1497:32\u201339. doi: 10.1016/j.brainres.2012.12.032.", "ArticleIdList": ["10.1016/j.brainres.2012.12.032", "23276496"]}, {"Citation": "Nguyen T., Nioi P., Pickett C. B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. Journal of Biological Chemistry. 2009;284(20):13291\u201313295. doi: 10.1074/jbc.R900010200.", "ArticleIdList": ["10.1074/jbc.R900010200", "PMC2679427", "19182219"]}, {"Citation": "Tebay L. E., Robertson H., Durant S. T., et al. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radical Biology & Medicine. 2015;88(Part B):108\u2013146. doi: 10.1016/j.freeradbiomed.2015.06.021.", "ArticleIdList": ["10.1016/j.freeradbiomed.2015.06.021", "PMC4659505", "26122708"]}, {"Citation": "Chen K., Gunter K., Maines M. D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. Journal of Neurochemistry. 2000;75(1):304\u2013313. doi: 10.1046/j.1471-4159.2000.0750304.x.", "ArticleIdList": ["10.1046/j.1471-4159.2000.0750304.x", "10854275"]}, {"Citation": "Bruns D. R., Drake J. C., Biela L. M., Peelor F. F., Miller B. F., Hamilton K. L. Nrf2 signaling and the slowed aging phenotype: evidence from long-lived models. Oxidative Medicine and Cellular Longevity. 2015;2015:15. doi: 10.1155/2015/732596.732596", "ArticleIdList": ["10.1155/2015/732596", "PMC4637130", "26583062"]}, {"Citation": "Sun Y., Yang T., Leak R. K., Chen J., Zhang F. Preventive and protective roles of dietary Nrf2 activators against central nervous system diseases. CNS & Neurological Disorders - Drug Targets. 2017;16(3):326\u2013338. doi: 10.2174/1871527316666170102120211.", "ArticleIdList": ["10.2174/1871527316666170102120211", "PMC5494269", "28042770"]}, {"Citation": "Cuadrado A. NRF2 in neurodegenerative diseases. Current Opinion in Toxicology. 2016;1:46\u201353. doi: 10.1016/j.cotox.2016.09.004.", "ArticleIdList": ["10.1016/j.cotox.2016.09.004"]}, {"Citation": "Wang Y., Li L., Deng S., Liu F., He Z. Ursolic acid ameliorates inflammation in cerebral ischemia and reperfusion injury possibly via high mobility group box 1/toll-like receptor 4/NF-\u03baB pathway. Frontiers in Neurology. 2018;9:p. 253. doi: 10.3389/fneur.2018.00253.", "ArticleIdList": ["10.3389/fneur.2018.00253", "PMC5968106", "29867706"]}, {"Citation": "Yang Q. W., Wang J. Z., Li J. C., et al. High-mobility group protein box-1 and its relevance to cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. 2009;30(2):243\u2013254. doi: 10.1038/jcbfm.2009.202.", "ArticleIdList": ["10.1038/jcbfm.2009.202", "PMC2949127", "19794402"]}, {"Citation": "Qiu J., Nishimura M., Wang Y., et al. Early release of HMGB-1 from neurons after the onset of brain ischemia. Journal of Cerebral Blood Flow & Metabolism. 2008;28(5):927\u2013938. doi: 10.1038/sj.jcbfm.9600582.", "ArticleIdList": ["10.1038/sj.jcbfm.9600582", "18000511"]}, {"Citation": "Wang Y., He Z., Deng S. Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury. Drug Design, Development and Therapy. 2016;10:1663\u20131674. doi: 10.2147/DDDT.S103829.", "ArticleIdList": ["10.2147/DDDT.S103829", "PMC4876798", "27274199"]}, {"Citation": "Alzheimer\u2019s Disease International. Dementia statistics.  2019,  https://www.alz.co.uk/research/statistics."}, {"Citation": "dos Santos Picanco L. C., Ozela P. F., de Fatima de Brito Brito M., et al. Alzheimer\u2019s disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment. Current Medicinal Chemistry. 2018;25(26):3141\u20133159. doi: 10.2174/0929867323666161213101126.", "ArticleIdList": ["10.2174/0929867323666161213101126", "30191777"]}, {"Citation": "Medina M. An overview on the clinical development of tau-based therapeutics. International Journal of Molecular Sciences. 2018;19(4):p. 1160. doi: 10.3390/ijms19041160.", "ArticleIdList": ["10.3390/ijms19041160", "PMC5979300", "29641484"]}, {"Citation": "Mullane K., Williams M. Alzheimer\u2019s disease (AD) therapeutics \u2013 2: beyond amyloid \u2013 re-defining AD and its causality to discover effective therapeutics. Biochemical Pharmacology. 2018;158:376\u2013401. doi: 10.1016/j.bcp.2018.09.027.", "ArticleIdList": ["10.1016/j.bcp.2018.09.027", "30273552"]}, {"Citation": "Sharma P., Srivastava P., Seth A., Tripathi P. N., Banerjee A. G., Shrivastava S. K. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies. Progress in Neurobiology. 2019;174:53\u201389. doi: 10.1016/j.pneurobio.2018.12.006.", "ArticleIdList": ["10.1016/j.pneurobio.2018.12.006", "30599179"]}, {"Citation": "Tang F. R., Loke W. K., Wong P., Khoo B. C. Radioprotective effect of ursolic acid in radiation-induced impairment of neurogenesis, learning and memory in adolescent BALB/c mouse. Physiology & Behavior. 2017;175:37\u201346. doi: 10.1016/j.physbeh.2017.03.027.", "ArticleIdList": ["10.1016/j.physbeh.2017.03.027", "28341234"]}, {"Citation": "Wu D. M., Lu J., Zhang Y. Q., et al. Ursolic acid improves domoic acid-induced cognitive deficits in mice. Toxicology and Applied Pharmacology. 2013;271(2):127\u2013136. doi: 10.1016/j.taap.2013.04.038.", "ArticleIdList": ["10.1016/j.taap.2013.04.038", "23707761"]}, {"Citation": "Teitelbaum J. S., Zatorre R. J., Carpenter S., et al. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. New England Journal of Medicine. 1990;322(25):1781\u20131787. doi: 10.1056/NEJM199006213222505.", "ArticleIdList": ["10.1056/NEJM199006213222505", "1971710"]}, {"Citation": "Lu J., Wu D. M., Zheng Y. L., Hu B., Cheng W., Zhang Z. F. Purple sweet potato color attenuates domoic acid-induced cognitive deficits by promoting estrogen receptor-\u03b1-mediated mitochondrial biogenesis signaling in mice. Free Radical Biology & Medicine. 2012;52(3):646\u2013659. doi: 10.1016/j.freeradbiomed.2011.11.016.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.11.016", "22178976"]}, {"Citation": "Shih Y. H., Chein Y. C., Wang J. Y., Fu Y. S. Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats. Neuroscience Letters. 2004;362(2):136\u2013140. doi: 10.1016/j.neulet.2004.03.011.", "ArticleIdList": ["10.1016/j.neulet.2004.03.011", "15193771"]}, {"Citation": "Lu J., Zheng Y. L., Wu D. M., Luo L., Sun D. X., Shan Q. Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Biochemical Pharmacology. 2007;74(7):1078\u20131090. doi: 10.1016/j.bcp.2007.07.007.", "ArticleIdList": ["10.1016/j.bcp.2007.07.007", "17692828"]}, {"Citation": "Bahrami S. A., Bakhtiari N. Ursolic acid regulates aging process through enhancing of metabolic sensor proteins level. Biomedicine & Pharmacotherapy. 2016;82:8\u201314. doi: 10.1016/j.biopha.2016.04.047.", "ArticleIdList": ["10.1016/j.biopha.2016.04.047", "27470332"]}, {"Citation": "Akasaka-Manya K., Manya H., Endo T. Function and change with aging of \u03b1-Klotho in the kidney. Vitamins & Hormones. 2016;101:239\u2013256. doi: 10.1016/bs.vh.2016.02.006.", "ArticleIdList": ["10.1016/bs.vh.2016.02.006", "27125745"]}, {"Citation": "Cararo-Lopes M. M., Mazucanti C. H. Y., Scavone C., Kawamoto E. M., Berwick D. C. The relevance of \u03b1-Klotho to the central nervous system: some key questions. Ageing Research Reviews. 2017;36:137\u2013148. doi: 10.1016/j.arr.2017.03.003.", "ArticleIdList": ["10.1016/j.arr.2017.03.003", "28323064"]}, {"Citation": "Kurosu H., Yamamoto M., Clark J. D., et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309(5742):1829\u20131833. doi: 10.1126/science.1112766.", "ArticleIdList": ["10.1126/science.1112766", "PMC2536606", "16123266"]}, {"Citation": "Xu Y., Sun Z. Molecular basis of Klotho: from gene to function in aging. Endocrine Reviews. 2015;36(2):174\u2013193. doi: 10.1210/er.2013-1079.", "ArticleIdList": ["10.1210/er.2013-1079", "PMC4399270", "25695404"]}, {"Citation": "Gharibi S., Bakhtiari N., Jalalvand E. M., Bakhtiari F. Ursolic acid mediates hepatic protection through enhancing of anti-aging biomarkers. Current Aging Science. 2018;11(1):16\u201323. doi: 10.2174/1874609810666170531103140.", "ArticleIdList": ["10.2174/1874609810666170531103140", "28558631"]}, {"Citation": "Lu J., Wu D. M., Zheng Y. L., et al. Ursolic acid attenuates D-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-\u03baB pathway activation. Cerebral Cortex. 2010;20(11):2540\u20132548. doi: 10.1093/cercor/bhq002.", "ArticleIdList": ["10.1093/cercor/bhq002", "20133359"]}, {"Citation": "Wang Y. J., Lu J., Wu D. M., et al. Ursolic acid attenuates lipopolysaccharide-induced cognitive deficits in mouse brain through suppressing p38/NF-\u03baB mediated inflammatory pathways. Neurobiology of Learning and Memory. 2011;96(2):156\u2013165. doi: 10.1016/j.nlm.2011.03.010.", "ArticleIdList": ["10.1016/j.nlm.2011.03.010", "21496491"]}, {"Citation": "Lu J., Wu D. M., Zheng Y. L., et al. Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and I\u03baB kinase \u03b2/nuclear factor-\u03baB-mediated inflammatory pathways in mice. Brain, Behavior, and Immunity. 2011;25(8):1658\u20131667. doi: 10.1016/j.bbi.2011.06.009.", "ArticleIdList": ["10.1016/j.bbi.2011.06.009", "21708244"]}, {"Citation": "Mourya A., Akhtar A., Ahuja S., Sah S. P., Kumar A. Synergistic action of ursolic acid and metformin in experimental model of insulin resistance and related behavioral alterations. European Journal of Pharmacology. 2018;835:31\u201340. doi: 10.1016/j.ejphar.2018.07.056.", "ArticleIdList": ["10.1016/j.ejphar.2018.07.056", "30075220"]}, {"Citation": "Liang W., Zhao X., Feng J., Song F., Pan Y. Ursolic acid attenuates beta-amyloid-induced memory impairment in mice. Arquivos de Neuro-Psiquiatria. 2016;74(6):482\u2013488. doi: 10.1590/0004-282x20160065.", "ArticleIdList": ["10.1590/0004-282x20160065", "27332074"]}, {"Citation": "Yoon J. H., Youn K., Ho C. T., Karwe M. V., Jeong W. S., Jun M. p-Coumaric acid and ursolic acid from Corni fructus attenuated \u03b2-amyloid25\u201335-induced toxicity through regulation of the NF-\u03baB signaling pathway in PC12 cells. Journal of Agricultural and Food Chemistry. 2014;62(21):4911\u20134916. doi: 10.1021/jf501314g.", "ArticleIdList": ["10.1021/jf501314g", "24815946"]}, {"Citation": "Heo H. J., Cho H. Y., Hong B., et al. Ursolic acid of Origanum majorana L. reduces A\u03b2-induced oxidative injury. Molecules and Cells. 2002;13(1):5\u201311.", "ArticleIdList": ["11911474"]}, {"Citation": "Hong S. Y., Jeong W. S., Jun M. Protective effects of the key compounds isolated from Corni fructus against \u03b2-amyloid-induced neurotoxicity in PC12 cells. Molecules. 2012;17(9):10831\u201310845. doi: 10.3390/molecules170910831.", "ArticleIdList": ["10.3390/molecules170910831", "PMC6268534", "22964500"]}, {"Citation": "Wilkinson K., Boyd J. D., Glicksman M., Moore K. J., El Khoury J. A high content drug screen identifies ursolic acid as an inhibitor of amyloid \u03b2 protein interactions with its receptor CD36. Journal of Biological Chemistry. 2011;286(40):34914\u201334922. doi: 10.1074/jbc.M111.232116.", "ArticleIdList": ["10.1074/jbc.M111.232116", "PMC3186388", "21835916"]}, {"Citation": "Coraci I. S., Husemann J., Berman J. W., et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer\u2019s disease brains and can mediate production of reactive oxygen species in response to \u03b2-amyloid fibrils. The American Journal of Pathology. 2002;160(1):101\u2013112. doi: 10.1016/S0002-9440(10)64354-4.", "ArticleIdList": ["10.1016/S0002-9440(10)64354-4", "PMC1867121", "11786404"]}, {"Citation": "El Khoury J. B., Moore K. J., Means T. K., et al. CD36 mediates the innate host response to \u03b2-amyloid. The Journal of Experimental Medicine. 2003;197(12):1657\u20131666. doi: 10.1084/jem.20021546.", "ArticleIdList": ["10.1084/jem.20021546", "PMC2193948", "12796468"]}, {"Citation": "Chung Y. K., Heo H. J., Kim E. K., et al. Inhibitory effect of ursolic acid purified from Origanum majorana L. on the acetylcholinesterase. Molecules and Cells. 2001;11(2):137\u2013143.", "ArticleIdList": ["11355692"]}, {"Citation": "Loesche A., K\u00f6witsch A., Lucas S. D., et al. Ursolic and oleanolic acid derivatives with cholinesterase inhibiting potential. Bioorganic Chemistry. 2019;85:23\u201332. doi: 10.1016/j.bioorg.2018.12.013.", "ArticleIdList": ["10.1016/j.bioorg.2018.12.013", "30599410"]}, {"Citation": "Felger J. C. Imaging the role of inflammation in mood and anxiety-related disorders. Current Neuropharmacology. 2018;16(5):533\u2013558. doi: 10.2174/1570159X15666171123201142.", "ArticleIdList": ["10.2174/1570159X15666171123201142", "PMC5997866", "29173175"]}, {"Citation": "Syed S. A., Beurel E., Loewenstein D. A., et al. Defective inflammatory pathways in never-treated depressed patients are associated with poor treatment response. Neuron. 2018;99(5):914\u2013924.e3. doi: 10.1016/j.neuron.2018.08.001.", "ArticleIdList": ["10.1016/j.neuron.2018.08.001", "PMC6151182", "30146307"]}, {"Citation": "Leng L., Zhuang K., Liu Z., et al. Menin deficiency leads to depressive-like behaviors in mice by modulating astrocyte-mediated neuroinflammation. Neuron. 2018;100(3):551\u2013563.e7. doi: 10.1016/j.neuron.2018.08.031.", "ArticleIdList": ["10.1016/j.neuron.2018.08.031", "30220511"]}, {"Citation": "Ma L., Demin K. A., Kolesnikova T. O., et al. Animal inflammation-based models of depression and their application to drug discovery. Expert Opinion on Drug Discovery. 2017;12(10):995\u20131009. doi: 10.1080/17460441.2017.1362385.", "ArticleIdList": ["10.1080/17460441.2017.1362385", "28816544"]}, {"Citation": "Grygiel-G\u00f3rniak B., Limphaibool N., Puszczewicz M. Cytokine secretion and the risk of depression development in patients with connective tissue diseases. Psychiatry and Clinical Neurosciences. 2019 doi: 10.1111/pcn.12826. In press.", "ArticleIdList": ["10.1111/pcn.12826", "30719813"]}, {"Citation": "Fourrier C., Singhal G., Baune B. T. Neuroinflammation and cognition across psychiatric conditions. CNS Spectrums. 2019;24(1):4\u201315. doi: 10.1017/S1092852918001499.", "ArticleIdList": ["10.1017/S1092852918001499", "30714555"]}, {"Citation": "Chan K. L., Cathomas F., Russo S. J. Central and peripheral inflammation link metabolic syndrome and major depressive disorder. Physiology. 2019;34(2):123\u2013133. doi: 10.1152/physiol.00047.2018.", "ArticleIdList": ["10.1152/physiol.00047.2018", "PMC6586832", "30724127"]}, {"Citation": "Tolkien K., Bradburn S., Murgatroyd C. An anti-inflammatory diet as a potential intervention for depressive disorders: a systematic review and meta-analysis. Clinical Nutrition. 2018 doi: 10.1016/j.clnu.2018.11.007. In press.", "ArticleIdList": ["10.1016/j.clnu.2018.11.007", "30502975"]}, {"Citation": "Fedoce A. D. G., Ferreira F., Bota R. G., Bonet-Costa V., Sun P. Y., Davies K. J. A. The role of oxidative stress in anxiety disorder: cause or consequence? Free Radical Research. 2018;52(7):737\u2013750. doi: 10.1080/10715762.2018.1475733.", "ArticleIdList": ["10.1080/10715762.2018.1475733", "PMC6218334", "29742940"]}, {"Citation": "Hritcu L., Ionita R., Postu P. A., et al. Antidepressant flavonoids and their relationship with oxidative stress. Oxidative Medicine and Cellular Longevity. 2017;2017:18. doi: 10.1155/2017/5762172.5762172", "ArticleIdList": ["10.1155/2017/5762172", "PMC5749298", "29410733"]}, {"Citation": "Nieoczym D., Soca\u0142a K., Wla\u017a P. Assessment of the anticonvulsant potency of ursolic acid in seizure threshold tests in mice. Neurochemical Research. 2018;43(5):995\u20131002. doi: 10.1007/s11064-018-2505-z.", "ArticleIdList": ["10.1007/s11064-018-2505-z", "PMC5949134", "29541930"]}, {"Citation": "Taviano M. F., Miceli N., Monforte M. T., Tzakou O., Galati E. M. Ursolic acid plays a role in Nepeta sibthorpii Bentham CNS depressing effects. Phytotherapy Research. 2007;21(4):382\u2013385. doi: 10.1002/ptr.2076.", "ArticleIdList": ["10.1002/ptr.2076", "17236171"]}, {"Citation": "Brocardo P. S., Budni J., Lobato K. R., Santos A. R. S., Rodrigues A. L. S. Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test. Behavioural Brain Research. 2009;200(1):122\u2013127. doi: 10.1016/j.bbr.2009.01.004.", "ArticleIdList": ["10.1016/j.bbr.2009.01.004", "19162083"]}, {"Citation": "Schreiber S., Bleich A., Pick C. G. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects\u2014a possible opioid involvement in severe depression? Journal of Molecular Neuroscience. 2002;18(1-2):143\u2013150. doi: 10.1385/JMN:18:1-2:143.", "ArticleIdList": ["10.1385/JMN:18:1-2:143", "11931344"]}, {"Citation": "Machado D. G., Neis V. B., Balen G. O., et al. Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice: evidence for the involvement of the dopaminergic system. Pharmacology Biochemistry and Behavior. 2012;103(2):204\u2013211. doi: 10.1016/j.pbb.2012.08.016.", "ArticleIdList": ["10.1016/j.pbb.2012.08.016", "22940588"]}, {"Citation": "Colla A. R. S., Oliveira \u00c1., Pazini F. L., et al. Serotonergic and noradrenergic systems are implicated in the antidepressant-like effect of ursolic acid in mice. Pharmacology Biochemistry and Behavior. 2014;124:108\u2013116. doi: 10.1016/j.pbb.2014.05.015.", "ArticleIdList": ["10.1016/j.pbb.2014.05.015", "24887451"]}, {"Citation": "Colla A. R. S., Rosa J. M., Cunha M. P., Rodrigues A. L. S. Anxiolytic-like effects of ursolic acid in mice. European Journal of Pharmacology. 2015;758:171\u2013176. doi: 10.1016/j.ejphar.2015.03.077.", "ArticleIdList": ["10.1016/j.ejphar.2015.03.077", "25861934"]}, {"Citation": "Verano J., Gonz\u00e1lez-Trujano M. E., D\u00e9ciga-Campos M., Ventura-Mart\u00ednez R., Pellicer F. Ursolic acid from Agastache mexicana aerial parts produces antinociceptive activity involving TRPV1 receptors, cGMP and a serotonergic synergism. Pharmacology Biochemistry and Behavior. 2013;110:255\u2013264. doi: 10.1016/j.pbb.2013.07.020.", "ArticleIdList": ["10.1016/j.pbb.2013.07.020", "23932918"]}, {"Citation": "Ramos-Hryb A. B., Cunha M. P., Pazini F. L., et al. Ursolic acid affords antidepressant-like effects in mice through the activation of PKA, PKC, CAMK-II and MEK1/2. Pharmacological Reports. 2017;69(6):1240\u20131246. doi: 10.1016/j.pharep.2017.05.009.", "ArticleIdList": ["10.1016/j.pharep.2017.05.009", "29128805"]}, {"Citation": "Liu J. H., Wu Z. F., Sun J., Jiang L., Jiang S., Fu W. B. Role of AC-cAMP-PKA cascade in antidepressant action of electroacupuncture treatment in rats. Evidence-Based Complementary and Alternative Medicine. 2012;2012:7. doi: 10.1155/2012/932414.932414", "ArticleIdList": ["10.1155/2012/932414", "PMC3369237", "22693534"]}, {"Citation": "R\u00e9us G. Z., Stringari R. B., Ribeiro K. F., et al. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behavioural Brain Research. 2011;221(1):166\u2013171. doi: 10.1016/j.bbr.2011.02.024.", "ArticleIdList": ["10.1016/j.bbr.2011.02.024", "21397634"]}, {"Citation": "Tiraboschi E., Giambelli R., D\u2019Urso G., et al. Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. NeuroReport. 2004;15(15):2393\u20132396. doi: 10.1097/00001756-200410250-00018.", "ArticleIdList": ["10.1097/00001756-200410250-00018", "15640762"]}, {"Citation": "Duman C. H., Schlesinger L., Kodama M., Russell D. S., Duman R. S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biological Psychiatry. 2007;61(5):661\u2013670. doi: 10.1016/j.biopsych.2006.05.047.", "ArticleIdList": ["10.1016/j.biopsych.2006.05.047", "16945347"]}, {"Citation": "Khan I., Karim N., Ahmad W., Abdelhalim A., Chebib M. GABA-A receptor modulation and anticonvulsant, anxiolytic, and antidepressant activities of constituents from Artemisia indica Linn. Evidence-Based Complementary and Alternative Medicine. 2016;2016:12. doi: 10.1155/2016/1215393.1215393", "ArticleIdList": ["10.1155/2016/1215393", "PMC4838807", "27143980"]}, {"Citation": "Jeon S. J., Park H. J., Gao Q., et al. Ursolic acid enhances pentobarbital-induced sleeping behaviors via GABAergic neurotransmission in mice. European Journal of Pharmacology. 2015;762:443\u2013448. doi: 10.1016/j.ejphar.2015.06.037.", "ArticleIdList": ["10.1016/j.ejphar.2015.06.037", "26102564"]}, {"Citation": "Awad R., Muhammad A., Durst T., Trudeau V. L., Arnason J. T. Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytotherapy Research. 2009;23(8):1075\u20131081. doi: 10.1002/ptr.2712.", "ArticleIdList": ["10.1002/ptr.2712", "19165747"]}, {"Citation": "Singla R. K., Scotti L., Dubey A. K. In silico studies revealed multiple neurological targets for the antidepressant molecule ursolic acid. Current Neuropharmacology. 2017;15(8):1100\u20131106. doi: 10.2174/1570159X14666161229115508.", "ArticleIdList": ["10.2174/1570159X14666161229115508", "PMC5725542", "28034283"]}, {"Citation": "Kim J. H., Kim G. H., Hwang K. H. Monoamine oxidase and dopamine \u03b2-hydroxylase inhibitors from the fruits of Gardenia jasminoides. Biomolecules & Therapeutics. 2012;20(2):214\u2013219. doi: 10.4062/biomolther.2012.20.2.214.", "ArticleIdList": ["10.4062/biomolther.2012.20.2.214", "PMC3792221", "24116298"]}, {"Citation": "Appel S. H., Beers D. R., Henkel J. S. T cell-microglial dialogue in Parkinson\u2019s disease and amyotrophic lateral sclerosis: are we listening? Trends in Immunology. 2010;31(1):7\u201317. doi: 10.1016/j.it.2009.09.003.", "ArticleIdList": ["10.1016/j.it.2009.09.003", "PMC4126423", "19879804"]}, {"Citation": "Chao Y., Wong S. C., Tan E. K. Evidence of inflammatory system involvement in Parkinson\u2019s disease. BioMed Research International. 2014;2014:9. doi: 10.1155/2014/308654.308654", "ArticleIdList": ["10.1155/2014/308654", "PMC4094726", "25050341"]}, {"Citation": "Mosley R. L., Benner E. J., Kadiu I., et al. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson\u2019s disease. Clinical Neuroscience Research. 2006;6(5):261\u2013281. doi: 10.1016/j.cnr.2006.09.006.", "ArticleIdList": ["10.1016/j.cnr.2006.09.006", "PMC1831679", "18060039"]}, {"Citation": "Var\u00e7in M., Bentea E., Michotte Y., Sarre S. Oxidative stress in genetic mouse models of Parkinson\u2019s disease. Oxidative Medicine and Cellular Longevity. 2012;2012:25. doi: 10.1155/2012/624925.624925", "ArticleIdList": ["10.1155/2012/624925", "PMC3399377", "22829959"]}, {"Citation": "Knott C., Stern G., Wilkin G. P. Inflammatory regulators in Parkinson\u2019s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Molecular and Cellular Neuroscience. 2000;16(6):724\u2013739. doi: 10.1006/mcne.2000.0914.", "ArticleIdList": ["10.1006/mcne.2000.0914", "11124893"]}, {"Citation": "Li M., Dai F. R., Du X. P., Yang Q. D., Chen Y. Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson\u2019s disease. Journal of Molecular Neuroscience. 2012;48(1):225\u2013233. doi: 10.1007/s12031-012-9814-5.", "ArticleIdList": ["10.1007/s12031-012-9814-5", "22638860"]}, {"Citation": "Wang Q., Zhang H., Liu M., et al. P38 MAPK signaling pathway regulates nuclear factor-\u03baB and inducible nitric oxide synthase expressions in the substantia nigra in a mouse model of Parkinson's disease. Journal of Southern Medical University. 2014;34(8):1176\u20131180.", "ArticleIdList": ["25176090"]}, {"Citation": "Wilms H., Rosenstiel P., Sievers J., Deuschl G., Zecca L., Lucius R. Activation of microglia by human neuromelanin is NF-\u03baB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson\u2019s disease. The FASEB Journal. 2003;17(3):500\u2013502. doi: 10.1096/fj.02-0314fje.", "ArticleIdList": ["10.1096/fj.02-0314fje", "12631585"]}, {"Citation": "Jha S. K., Jha N. K., Kar R., Ambasta R. K., Kumar P. p38 MAPK and PI3K/AKT signalling cascades in Parkinson\u2019s disease. International Journal of Molecular and Cellular Medicine. 2015;4(2):67\u201386.", "ArticleIdList": ["PMC4499569", "26261796"]}, {"Citation": "Karunakaran S., Ravindranath V. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-\u03baB in MPTP-treated mice: implication in Parkinson\u2019s disease. Journal of Neurochemistry. 2009;109(6):1791\u20131799. doi: 10.1111/j.1471-4159.2009.06112.x.", "ArticleIdList": ["10.1111/j.1471-4159.2009.06112.x", "19457134"]}, {"Citation": "Chan P., DeLanney L. E., Irwin I., Langston J. W., Monte D. Rapid ATP loss caused by 1\u2010methyl\u20104\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine in mouse brain. Journal of Neurochemistry. 1991;57(1):348\u2013351. doi: 10.1111/j.1471-4159.1991.tb02134.x.", "ArticleIdList": ["10.1111/j.1471-4159.1991.tb02134.x", "2051170"]}, {"Citation": "Gaki G. S., Papavassiliou A. G. Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson\u2019s disease. NeuroMolecular Medicine. 2014;16(2):217\u2013230. doi: 10.1007/s12017-014-8294-x.", "ArticleIdList": ["10.1007/s12017-014-8294-x", "24522549"]}, {"Citation": "Zhou C., Huang Y., Przedborski S. Oxidative stress in Parkinson\u2019s disease: a mechanism of pathogenic and therapeutic significance. Annals of the New York Academy of Sciences. 2008;1147(1):93\u2013104. doi: 10.1196/annals.1427.023.", "ArticleIdList": ["10.1196/annals.1427.023", "PMC2745097", "19076434"]}, {"Citation": "Rai S. N., Dilnashin H., Birla H., et al. The role of PI3K/Akt and ERK in neurodegenerative disorders. Neurotoxicity Research. 2019;35(3):775\u2013795. doi: 10.1007/s12640-019-0003-y.", "ArticleIdList": ["10.1007/s12640-019-0003-y", "30707354"]}, {"Citation": "Rai S. N., Yadav S. K., Singh D., Singh S. P. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. Journal of Chemical Neuroanatomy. 2016;71:41\u201349. doi: 10.1016/j.jchemneu.2015.12.002.", "ArticleIdList": ["10.1016/j.jchemneu.2015.12.002", "26686287"]}, {"Citation": "Habtemariam S. Protective effects of caffeic acid and the Alzheimer\u2019s brain: an update. Mini-Reviews in Medicinal Chemistry. 2017;17(8):667\u2013674. doi: 10.2174/1389557516666161130100947.", "ArticleIdList": ["10.2174/1389557516666161130100947", "27903226"]}, {"Citation": "Habtemariam S. The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs. Neural Regeneration Research. 2018;13(6):983\u2013984. doi: 10.4103/1673-5374.233438.", "ArticleIdList": ["10.4103/1673-5374.233438", "PMC6022464", "29926822"]}, {"Citation": "Habtemariam S. Rutin as a natural therapy for Alzheimer\u2019s disease: insights into its mechanisms of action. Current Medicinal Chemistry. 2016;23(9):860\u2013873. doi: 10.2174/0929867323666160217124333.", "ArticleIdList": ["10.2174/0929867323666160217124333", "26898570"]}, {"Citation": "Elufioye T. O., Berida T. I., Habtemariam S. Plants-derived neuroprotective agents: cutting the cycle of cell death through multiple mechanisms. Evidence-Based Complementary and Alternative Medicine. 2017;2017:27. doi: 10.1155/2017/3574012.3574012", "ArticleIdList": ["10.1155/2017/3574012", "PMC5585568", "28904554"]}, {"Citation": "Habtemariam S. The therapeutic potential of rosemary (Rosmarinus officinalis) diterpenes for Alzheimer\u2019s disease. Evidence-Based Complementary and Alternative Medicine. 2016;2016:14. doi: 10.1155/2016/2680409.2680409", "ArticleIdList": ["10.1155/2016/2680409", "PMC4749867", "26941822"]}, {"Citation": "Habtemariam S. Iridoids and other monoterpenes in the Alzheimer\u2019s brain: recent development and future prospects. Molecules. 2018;23(1):p. 117. doi: 10.3390/molecules23010117.", "ArticleIdList": ["10.3390/molecules23010117", "PMC6017424", "29316661"]}, {"Citation": "Habtemariam S. Going back to the good old days: the merit of crude plant drug mixtures in the 21st century. International Journal of Complementary & Alternative Medicine. 2017;6(2, article 00182) doi: 10.15406/ijcam.2017.06.00182.", "ArticleIdList": ["10.15406/ijcam.2017.06.00182"]}, {"Citation": "Xu H. L., Wang X. T., Cheng Y., et al. Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats. Biomedicine & Pharmacotherapy. 2018;105:915\u2013921. doi: 10.1016/j.biopha.2018.06.055.", "ArticleIdList": ["10.1016/j.biopha.2018.06.055", "30021385"]}, {"Citation": "Wang X. T., Gong Y., Zhou B., et al. Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats. Biomedicine & Pharmacotherapy. 2018;97:1461\u20131467. doi: 10.1016/j.biopha.2017.11.032.", "ArticleIdList": ["10.1016/j.biopha.2017.11.032", "29156537"]}, {"Citation": "Li J. S., Wang W. J., Sun Y., Zhang Y. H., Zheng L. Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress. Food & Function. 2015;6(5):1643\u20131651. doi: 10.1039/C5FO00083A.", "ArticleIdList": ["10.1039/C5FO00083A", "25892149"]}, {"Citation": "Li J., Li N., Yan S., et al. Ursolic acid alleviates inflammation and against diabetes-induced nephropathy through TLR4-mediated inflammatory pathway. Molecular Medicine Reports. 2018;18(5):4675\u20134681. doi: 10.3892/mmr.2018.9429.", "ArticleIdList": ["10.3892/mmr.2018.9429", "30221655"]}, {"Citation": "Wang E. M., Fan Q. L., Yue Y., Xu L. Ursolic acid attenuates high glucose-mediated mesangial cell injury by inhibiting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway. Medical Science Monitor. 2018;24:846\u2013854. doi: 10.12659/MSM.907814.", "ArticleIdList": ["10.12659/MSM.907814", "PMC5817901", "29428962"]}, {"Citation": "Ullevig S. L., Zhao Q., Zamora D., Asmis R. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis. 2011;219(2):409\u2013416. doi: 10.1016/j.atherosclerosis.2011.06.013.", "ArticleIdList": ["10.1016/j.atherosclerosis.2011.06.013", "PMC3199329", "21752377"]}, {"Citation": "Xiang M., Wang J., Zhang Y., Ling J., Xu X. Attenuation of aortic injury by ursolic acid through RAGE-Nox-NF-\u03baB pathway in streptozocin-induced diabetic rats. Archives of Pharmacal Research. 2012;35(5):877\u2013886. doi: 10.1007/s12272-012-0513-0.", "ArticleIdList": ["10.1007/s12272-012-0513-0", "22644855"]}, {"Citation": "Ram\u00edrez-Rodr\u00edguez A. M., Gonz\u00e1lez-Ortiz M., Mart\u00ednez-Abundis E., Acu\u00f1a Ortega N. Effect of ursolic acid on metabolic syndrome, insulin sensitivity, and inflammation. Journal of Medicinal Food. 2017;20(9):882\u2013886. doi: 10.1089/jmf.2017.0003.", "ArticleIdList": ["10.1089/jmf.2017.0003", "28598231"]}, {"Citation": "Zhang Y., Song C., Li H., Hou J., Li D. Ursolic acid prevents augmented peripheral inflammation and inflammatory hyperalgesia in high-fat diet-induced obese rats by restoring downregulated spinal PPAR\u03b1. Molecular Medicine Reports. 2016;13(6):5309\u20135316. doi: 10.3892/mmr.2016.5172.", "ArticleIdList": ["10.3892/mmr.2016.5172", "27108888"]}, {"Citation": "Li S., Meng F., Liao X., et al. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One. 2014;9(1, article e86724) doi: 10.1371/journal.pone.0086724.", "ArticleIdList": ["10.1371/journal.pone.0086724", "PMC3906058", "24489777"]}, {"Citation": "Li Q., Zhao W., Zeng X., Hao Z. Ursolic acid attenuates atherosclerosis in ApoE\u2212/\u2212 mice: role of LOX-1 mediated by ROS/NF-\u03baB pathway. Molecules. 2018;23(5):p. 1101. doi: 10.3390/molecules23051101.", "ArticleIdList": ["10.3390/molecules23051101", "PMC6100321", "29735887"]}, {"Citation": "Zhai M., Guo J., Ma H., et al. Ursolic acid prevents angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice. Atherosclerosis. 2018;271:128\u2013135. doi: 10.1016/j.atherosclerosis.2018.02.022.", "ArticleIdList": ["10.1016/j.atherosclerosis.2018.02.022", "29499360"]}, {"Citation": "Huang H. C., Huang C. Y., Lin-Shiau S. Y., Lin J. K. Ursolic acid inhibits IL\u20101\u03b2 or TNF\u2010\u03b1\u2010induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC\u2010\u03b6 and downregulating the MMP\u20109 expression. Molecular Carcinogenesis. 2009;48(6):517\u2013531. doi: 10.1002/mc.20490.", "ArticleIdList": ["10.1002/mc.20490", "18973186"]}, {"Citation": "Leng S., Iwanowycz S., Saaoud F., et al. Ursolic acid enhances macrophage autophagy and attenuates atherogenesis. Journal of Lipid Research. 2016;57(6):1006\u20131016. doi: 10.1194/jlr.M065888.", "ArticleIdList": ["10.1194/jlr.M065888", "PMC4878185", "27063951"]}, {"Citation": "Wang Y. L., Wang Z. J., Shen H. L., Yin M., Tang K. X. Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit. European Journal of Pharmaceutical Sciences. 2013;50(3-4):366\u2013371. doi: 10.1016/j.ejps.2013.08.003.", "ArticleIdList": ["10.1016/j.ejps.2013.08.003", "23954455"]}, {"Citation": "Ma J. Q., Ding J., Zhang L., Liu C. M. Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway. Clinics and Research in Hepatology and Gastroenterology. 2015;39(2):188\u2013197. doi: 10.1016/j.clinre.2014.09.007.", "ArticleIdList": ["10.1016/j.clinre.2014.09.007", "25459994"]}, {"Citation": "Ma J. Q., Ding J., Zhang L., Liu C. M. Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-\u03baB pathway. Environmental Toxicology and Pharmacology. 2014;37(3):975\u2013983. doi: 10.1016/j.etap.2014.03.011.", "ArticleIdList": ["10.1016/j.etap.2014.03.011", "24727148"]}, {"Citation": "Ma J. Q., Ding J., Xiao Z. H., Liu C. M. Ursolic acid ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney by inhibiting the STAT3 and NF-\u03baB activities. International Immunopharmacology. 2014;21(2):389\u2013395. doi: 10.1016/j.intimp.2014.05.022.", "ArticleIdList": ["10.1016/j.intimp.2014.05.022", "24880019"]}, {"Citation": "Li D., Ren D., Luo Y., Yang X. Protective effects of ursolic acid against hepatotoxicity and endothelial dysfunction in mice with chronic high choline diet consumption. Chemico-Biological Interactions. 2016;258:102\u2013107. doi: 10.1016/j.cbi.2016.08.019.", "ArticleIdList": ["10.1016/j.cbi.2016.08.019", "27567547"]}, {"Citation": "Saravanan R., Pugalendi V. Impact of ursolic acid on chronic ethanol-induced oxidative stress in the rat heart. Pharmacological Reports. 2006;58(1):41\u201347.", "ArticleIdList": ["16531629"]}, {"Citation": "Zhou W., Lin L., Cheng Y., Liu Y. Ursolic acid improves liver transplantation and inhibits apoptosis in miniature pigs using donation after cardiac death. Cellular Physiology and Biochemistry. 2017;43(1):331\u2013338. doi: 10.1159/000480413.", "ArticleIdList": ["10.1159/000480413", "28854432"]}, {"Citation": "Yang Y., Zhao Z., Liu Y., Kang X., Zhang H., Meng M. Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1\u2010AMP\u2010activated protein kinase signaling. Journal of Gastroenterology and Hepatology. 2015;30(3):609\u2013618. doi: 10.1111/jgh.12723.", "ArticleIdList": ["10.1111/jgh.12723", "25168399"]}, {"Citation": "Chen M., Wang X., Hu B., et al. Ursolic acid stimulates UCP2 expression and protects H9c2 cells from hypoxia-reoxygenation injury via p38 signaling. Journal of Biosciences. 2018;43(5):857\u2013865. doi: 10.1007/s12038-018-9801-2.", "ArticleIdList": ["10.1007/s12038-018-9801-2", "30541946"]}, {"Citation": "Peng J., Ren X., Lan T., Chen Y., Shao Z., Yang C. Renoprotective effects of ursolic acid on ischemia/reperfusion-induced acute kidney injury through oxidative stress, inflammation and the inhibition of STAT3 and NF-\u03baB activities. Molecular Medicine Reports. 2016;14(4):3397\u20133402. doi: 10.3892/mmr.2016.5654.", "ArticleIdList": ["10.3892/mmr.2016.5654", "27573738"]}, {"Citation": "Saravanan R., Viswanathan P., Pugalendi K. V. Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats. Life Sciences. 2006;78(7):713\u2013718. doi: 10.1016/j.lfs.2005.05.060.", "ArticleIdList": ["10.1016/j.lfs.2005.05.060", "16137716"]}, {"Citation": "Baek S. Y., Lee J., Lee D. G., et al. Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation. Acta Pharmacologica Sinica. 2014;35(9):1177\u20131187. doi: 10.1038/aps.2014.58.", "ArticleIdList": ["10.1038/aps.2014.58", "PMC4155530", "25087995"]}, {"Citation": "Kang S. Y., Yoon S. Y., Roh D. H., et al. The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models. Journal of Pharmacy and Pharmacology. 2008;60(10):1347\u20131354. doi: 10.1211/jpp.60.10.0011.", "ArticleIdList": ["10.1211/jpp.60.10.0011", "18812028"]}, {"Citation": "Bhat R. A., Lingaraju M. C., Pathak N. N., et al. Effect of ursolic acid in attenuating chronic constriction injury-induced neuropathic pain in rats. Fundamental & Clinical Pharmacology. 2016;30(6):517\u2013528. doi: 10.1111/fcp.12223.", "ArticleIdList": ["10.1111/fcp.12223", "27414466"]}, {"Citation": "Kim S. H., Hong J. H., Lee Y. C. Ursolic acid, a potential PPAR\u03b3 agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma. European Journal of Pharmacology. 2013;701(1-3):131\u2013143. doi: 10.1016/j.ejphar.2012.11.033.", "ArticleIdList": ["10.1016/j.ejphar.2012.11.033", "23201068"]}, {"Citation": "Lin L., Yin Y., Hou G., Han D., Kang J., Wang Q. Ursolic acid attenuates cigarette smoke-induced emphysema in rats by regulating PERK and Nrf2 pathways. Pulmonary Pharmacology & Therapeutics. 2017;44:111\u2013121. doi: 10.1016/j.pupt.2017.03.014.", "ArticleIdList": ["10.1016/j.pupt.2017.03.014", "28347799"]}, {"Citation": "Chen X., Wan Y., Zhou T., Li J., Wei Y. Ursolic acid attenuates lipopolysaccharide-induced acute lung injury in a mouse model. Immunotherapy. 2013;5(1):39\u201347. doi: 10.2217/imt.12.144.", "ArticleIdList": ["10.2217/imt.12.144", "23256797"]}, {"Citation": "Jang S. E., Jeong J. J., Hyam S. R., Han M. J., Kim D. H. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages. Journal of Agricultural and Food Chemistry. 2014;62(40):9711\u20139721. doi: 10.1021/jf501487v.", "ArticleIdList": ["10.1021/jf501487v", "25213465"]}, {"Citation": "Zhang Z., Zhang H., Chen R., Wang Z. Oral supplementation with ursolic acid ameliorates sepsis-induced acute kidney injury in a mouse model by inhibiting oxidative stress and inflammatory responses. Molecular Medicine Reports. 2018;17(5):7142\u20137148. doi: 10.3892/mmr.2018.8767.", "ArticleIdList": ["10.3892/mmr.2018.8767", "PMC5928665", "29568928"]}, {"Citation": "Hu Z., Gu Z., Sun M., et al. Ursolic acid improves survival and attenuates lung injury in septic rats induced by cecal ligation and puncture. Journal of Surgical Research. 2015;194(2):528\u2013536. doi: 10.1016/j.jss.2014.10.027.", "ArticleIdList": ["10.1016/j.jss.2014.10.027", "25454976"]}, {"Citation": "Zhang C., Wang C., Li W., et al. Pharmacokinetics and pharmacodynamics of the triterpenoid ursolic acid in regulating the antioxidant, anti-inflammatory, and epigenetic gene responses in rat leukocytes. Molecular Pharmaceutics. 2017;14(11):3709\u20133717. doi: 10.1021/acs.molpharmaceut.7b00469.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b00469", "PMC5697757", "29035547"]}, {"Citation": "Ma X., Zhang Y., Wang Z., et al. Ursolic acid, a natural nutraceutical agent, targets caspase3 and alleviates inflammation\u2010associated downstream signal transduction. Molecular Nutrition & Food Research. 2017;61(12) doi: 10.1002/mnfr.201700332.", "ArticleIdList": ["10.1002/mnfr.201700332", "PMC5765441", "28801966"]}]}], "History": [{"Year": "2019", "Month": "2", "Day": "27"}, {"Year": "2019", "Month": "4", "Day": "27"}, {"Year": "2019", "Month": "5", "Day": "8"}, {"Year": "2019", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["31223427", "PMC6541953", "10.1155/2019/8512048"]}}]}